{"id":"https://openalex.org/W3211255992","doi":"https://doi.org/10.53879/id.54.07.10746","title":"A NEW METHOD DEVELOPMENT AND VALIDATION FOR RELATED SUBSTANCES OF GRANISETRON IN ACTIVE PHARMA INGREDIENT BY HPLC","display_name":"A NEW METHOD DEVELOPMENT AND VALIDATION FOR RELATED SUBSTANCES OF GRANISETRON IN ACTIVE PHARMA INGREDIENT BY HPLC","publication_year":2017,"publication_date":"2017-07-28","ids":{"openalex":"https://openalex.org/W3211255992","doi":"https://doi.org/10.53879/id.54.07.10746","mag":"3211255992"},"language":"en","primary_location":{"id":"doi:10.53879/id.54.07.10746","doi":"https://doi.org/10.53879/id.54.07.10746","is_oa":false,"landing_page_url":"https://doi.org/10.53879/id.54.07.10746","pdf_url":null,"source":{"id":"https://openalex.org/S2764981170","display_name":"INDIAN DRUGS","issn_l":"0019-462X","issn":["0019-462X","3048-7161"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4353105718","host_organization_name":"Indian Drug Manufacturers' Association (IDMA)","host_organization_lineage":["https://openalex.org/P4353105718"],"host_organization_lineage_names":["Indian Drug Manufacturers' Association (IDMA)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"INDIAN DRUGS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020977338","display_name":"Tentu Nageswara Rao","orcid":"https://orcid.org/0000-0003-1835-0319","observed_orcids":["https://orcid.org/0000-0003-1835-0319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. N Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096708646","display_name":"Y. Prasanthi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Prasanthi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005685738","display_name":"Botsa Parvatamma","orcid":"https://orcid.org/0000-0002-9785-0401","observed_orcids":["https://orcid.org/0000-0002-9785-0401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Parvatamma Botsa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036716975","display_name":"G. Kumara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Kumara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"K. A. Rao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. A. Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"54","issue":"07","first_page":"52","last_page":"59"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/granisetron-hydrochloride","display_name":"granisetron hydrochloride","score":0.9559999704360962},{"id":"https://openalex.org/keywords/related-impurities","display_name":"related impurities","score":0.8610000014305115},{"id":"https://openalex.org/keywords/impurity-determination","display_name":"impurity determination","score":0.6700000166893005},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.6470000147819519},{"id":"https://openalex.org/keywords/hplc-method-development","display_name":"HPLC method development","score":0.7710000276565552},{"id":"https://openalex.org/keywords/indazole-derivatives","display_name":"indazole derivatives","score":0.6740000247955322},{"id":"https://openalex.org/keywords/pharmaceutical-impurity-analysis","display_name":"pharmaceutical impurity analysis","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7111728191375732},{"id":"https://openalex.org/C2780591553","wikidata":"https://www.wikidata.org/wiki/Q417106","display_name":"Indazole","level":2,"score":0.7002528309822083},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.694852352142334},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.6493061184883118},{"id":"https://openalex.org/C2781283055","wikidata":"https://www.wikidata.org/wiki/Q139199","display_name":"Triethylamine","level":2,"score":0.6403767466545105},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6275486946105957},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.539012610912323},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.5248739123344421},{"id":"https://openalex.org/C2778327999","wikidata":"https://www.wikidata.org/wiki/Q188777","display_name":"Carboxamide","level":2,"score":0.5094392895698547},{"id":"https://openalex.org/C2777463227","wikidata":"https://www.wikidata.org/wiki/Q408047","display_name":"Acetonitrile","level":2,"score":0.4506984055042267},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.16615590453147888},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12024584412574768}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53879/id.54.07.10746","doi":"https://doi.org/10.53879/id.54.07.10746","is_oa":false,"landing_page_url":"https://doi.org/10.53879/id.54.07.10746","pdf_url":null,"source":{"id":"https://openalex.org/S2764981170","display_name":"INDIAN DRUGS","issn_l":"0019-462X","issn":["0019-462X","3048-7161"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4353105718","host_organization_name":"Indian Drug Manufacturers' Association (IDMA)","host_organization_lineage":["https://openalex.org/P4353105718"],"host_organization_lineage_names":["Indian Drug Manufacturers' Association (IDMA)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"INDIAN DRUGS","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1968859817","https://openalex.org/W1974752244","https://openalex.org/W2004271176","https://openalex.org/W2067354767","https://openalex.org/W2068962765","https://openalex.org/W2185726153","https://openalex.org/W2186978827","https://openalex.org/W2299629815","https://openalex.org/W3080804757","https://openalex.org/W4239216879","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2383009050","https://openalex.org/W2392752031","https://openalex.org/W2186978827","https://openalex.org/W2380522959","https://openalex.org/W2496461117","https://openalex.org/W2080426333","https://openalex.org/W2185726153","https://openalex.org/W2797121463","https://openalex.org/W2370944095","https://openalex.org/W7019754789"],"abstract_inverted_index":{"A":[0,76],"simple":[1],"and":[2,20,30,98,122],"inexpensive":[3],"method":[4,108],"was":[5,82,94,105,109],"developed":[6],"using":[7,69],"high":[8],"performance":[9],"liquid":[10],"chromatography":[11],"with":[12,73],"PDA":[13],"detection":[14,121],"for":[15],"determination":[16],"of":[17,79,102,120,124],"granisetron":[18],"hydrochloride":[19],"related":[21],"impurities":[22,85],"(2-methyl-N-":[23],"[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide,":[24],"1-Methyl-N-[(1R,3r,5S)-":[25],"9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide":[26],"hydrochloride,":[27],"N-[(1R,3r,5S)-9-":[28],"azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide":[29],"1-methyl-1H-indazole-3-carboxylic":[31],"acid.":[32],"The":[33,91,107],"chromatographic":[34],"separations":[35],"were":[36,86],"achieved":[37],"on":[38],"(250\u00d74.6":[39],"mm),":[40],"5.0":[41],"\u03bcm":[42],"make:":[43],"Waters,":[44],"Symmetry":[45],"Shield":[46],"C8":[47],"column":[48,92],"employing":[49],"acetonitrile:":[50],"2%":[51],"V/V":[52,59,64],"H3PO4":[53],"in":[54,61],"MilliQ":[55],"water":[56],"+":[57],"0.1%":[58],"hexylamine":[60],"water,":[62],"800:200":[63],"(pH":[65],"adjusted":[66],"to":[67],"7.5":[68],"triethylamine)":[70],"mobile":[71],"phase":[72],"isocratic":[74],"programme.":[75],"flow":[77],"rate":[78],"1.5":[80],"mL/min":[81],"chosen.":[83],"Four":[84],"eluted":[87],"within":[88],"20":[89],"minutes.":[90],"temperature":[93],"maintained":[95],"at":[96],"40\u00b0C":[97],"a":[99],"detector":[100],"wavelength":[101],"300":[103],"nm":[104],"employed.":[106],"successfully":[110],"validated":[111],"by":[112],"establishing":[113],"system":[114],"suitability,":[115],"specificity,":[116],"linearity,":[117],"accuracy,":[118],"limit":[119,123],"quantification.":[125]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-11-08T00:00:00"}